Ultragenyx Pharmaceutical Inc. has announced the grant of non-qualified stock options and restricted stock units to a newly hired non-executive officer employee. The employee has received options to purchase 62,232 shares of common stock at an exercise price of $30.08 per share, along with 34,564 restricted stock units. The stock options will vest over four years, with 25% vesting after one year and the remainder vesting monthly thereafter. The restricted stock units will vest in equal annual installments over four years. The grant date for these awards was September 30, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9538717-en) on October 03, 2025, and is solely responsible for the information contained therein.